OPX Biotechnologies

Developing and commercializing cost effective bio.

Information, communication & technology | Northern America | Energy and Fuel Efficiency

 

• 
• 
• http://www.opxbiotechnologies.com

Overview

OPXBIO uses its proprietary leading EDGE (Efficiency Directed Genome Engineering) technology to manufacture renewable bio based chemicals and fuels that are lower cost higher return and more sustainable than existing petroleum based products. In addition to DBL Investors investors includeX/Seed Capital USRG Mohr Davidow Braemar Energy Ventures and Wolfensohn & Co.

Industry	Legal Structure	Operating Status	Employees
Information, communication & technology		Acquired	51 - 200 employees

Funding and Financing Rounds

Team

Impact

Social Objectives:

Environmental Objectives:

Operational Impact:

Impact Reports & Metrics

Offices